RedixFi
RedixFi

KRSNAA · Concall Summary

KRSNAA DIAGNOSTICS LTD

Concall2026-08-19
Tone: Positive

Krsnaa Diagnostics Limited held its Q1 FY27 earnings conference call on August 14, 2026, where management discussed the company's vision to enhance diagnostic accessibility across India. Management reported a 22% year-on-year revenue growth, with a notable 64% increase in retail revenue. The company has expanded its retail network to over 4,000 touchpoints and recently secured a significant CT project in Himachal Pradesh, increasing its operational centers from 12 to 34. Management highlighted that while margins faced compression due to upfront costs associated with new projects, like-to-like business margins remained stable. The CFO noted that revenue from operations reached INR 2,355 million, with an EBITDA margin of 25%. Management expressed confidence in achieving EBITDA positivity by Q2 FY27 and emphasized the importance of execution and operational efficiency moving forward. The call concluded with management inviting further inquiries from investors.

Management emphasized growth and operational achievements throughout the discussion.

View source filing →

Earlier concalls

  • 2026-08-14The investor presentation from Krsnaa Diagnostics Limited, dated August 14, 2026, provided an overview of the company's
  • 2026-05-29Krsnaa Diagnostics Limited held its Q4 FY '26 earnings conference call on May 26, 2026, to discuss its financial results
  • 2026-05-25Krsnaa Diagnostics Limited reported its financial results for the quarter and year ended March 31, 2026, highlighting it

See KRSNAA's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.

Sign up free

Back to KRSNAA snapshot